Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Hepatitis E Virus"
Deadline for manuscript submissions: closed (30 April 2019).
Infections with hepatitis E virus (HEV), a member of the hepeviridae, remain a major medical concern in developing countries but have also emerged as a health threat in specific patient populations in industrialized countries. HEV causes a broad range of clinical manifestations and disease severities, which remain incompletely understood. In contrast to the other human hepatitis viruses, HEV is found in an ever-increasing range of species, which raises interesting questions about the restrictions—or the lack thereof—of the zoonotic reservoir. Although a vaccine for HEV has been developed, it is only licensed in China. Additionally, no effective, non-teratogenic, or specific treatments against HEV infections are currently available. Although progress has been made in characterizing HEV biology, the scarcity of adequate experimental platforms has previously hampered research. With the advent of new model systems, a clearer picture of the mechanistic details of the HEV life-cycle starts to emerge, along with how this virus interacts with its different hosts.
This Special Issue is designed to provide an up-to-date view of HEV biology, including the molecular biology of the virus, virus–host interactions, and the development of new therapies.
Prof. Dr. Alexander Ploss
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.